[HTML][HTML] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann, CD Baldus - Molecular and cellular therapies, 2015 - Springer
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann… - Molecular and cellular …, 2015 - pubmed.ncbi.nlm.nih.gov
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
[引用][C] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann, CD Baldus - Molecular and Cellular …, 2015 - cir.nii.ac.jp
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, L Mochmann… - … Cellular Therapy and …, 2015 - journal.riverpublishers.com
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
[HTML][HTML] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann… - Molecular and …, 2015 - molcelltherapies.biomedcentral.com
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann, CD Baldus - Molecular and Cellular …, 2015 - go.gale.com
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.
L Fransecky, LH Mochmann… - Molecular and Cellular …, 2015 - europepmc.org
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
[PDF][PDF] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, LH Mochmann, CD Baldus - 2015 - Citeseer
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
[PDF][PDF] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, L Mochmann… - … Cellular Therapy and …, 2015 - journal.riverpublishers.com
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …
[引用][C] Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
L Fransecky, L Mochmann… - Molecular and Cellular …, 2015 - riverpublishersjournal.com
Technological advances allowing high throughput analyses across numerous cancer
tissues have allowed much progress in understanding complex cellular signaling. In the …
tissues have allowed much progress in understanding complex cellular signaling. In the …